Pfizer to make 23 medicines available for developing countries at low prices

June 4, 2022

Five Things to Know in October Third & Fourth Week

December 10, 2022

BD to Divest Biosciences and Diagnostics Units to Waters in $17.5 Billion Reverse Morris Trust Deal

July 14, 2025

Must Read

GSK will increase its R&D efforts by investing £400 million in Britain over three years

July 30, 2026

Hansoh Announces Fresh Phase 3 Victory For Priority ADC

July 30, 2026

Altimmune Reports Phase 2 Pemvidutide Results in Alcohol Use Disorder

July 28, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Hansoh Announces Fresh Phase 3 Victory For Priority ADC

Altimmune Reports Phase 2 Pemvidutide Results in Alcohol Use Disorder

Sanofi Ends Amlitelimab Development in Atopic Dermatitis After Phase 3 Program Review

J&J’s Bispecific Combination Works Wonders on Myeloma Progression in Phase 3 Study

GSK will increase its R&D efforts by investing £400 million in Britain over three years

Included Health Agrees to Acquire Firefly Health to Expand Employer Health Plan Alternatives

Argenx purchases Forte for $2.2 billion to enter the hands-on phase two-stage medication for vitiligo

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

The Workforce Challenge Facing Biopharma Manufacturing

What Pharma Leaders Are Prioritizing in 2026

How RNA Therapeutics Are Expanding Beyond Rare Diseases

The Future of AI-Assisted Clinical Operations

Tag: Japan

Japan-based Nipro Pharma Packaging acquires Croatian manufacturer Piramida

Editor Picks

Pfizer to make 23 medicines available for developing countries at low prices

Five Things to Know in October Third & Fourth Week

BD to Divest Biosciences and Diagnostics Units to Waters in $17.5 Billion Reverse Morris Trust Deal

Must Read

GSK will increase its R&D efforts by investing £400 million in Britain over three years

Hansoh Announces Fresh Phase 3 Victory For Priority ADC

Altimmune Reports Phase 2 Pemvidutide Results in Alcohol Use Disorder

Hot Topics

About Us

Follow Us